References
- von der Maase H, Borth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J 1986; 293: 1398–401.
- Berthelsen JG, Skakkebaek NE. Value of testicular biopsy in diagnosing carcinoma in situ testis. Scand J Urol Nephrol 1981; 15: 165–8.
- Giwercman A, von der Maase H, Berthelsen JG, Rorth M, Bertelsen A, Skakkebaek NE. Localized irradiation of testis with carcinoma in situ: effects of Leydig cellfunction and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991; 73: 596–603.
- Bottomley D, Fisher C, Hendry WF, Horwich A. Persistent carcinoma situ of the testis after chemotherapy for advanced testicular germ cell tumours. Br J Urol 1990; 66: 420–4.
- Dieckmann K-P, Loy V. Intratesticular effects of cisplatin-based chemotherapy. Eur Urol 1995; 28: 25–30.
- Simmonds PD, Mead GM, Lee AH, Theaker JM, Dewbury K, Smart CJ. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated? Cancer 1995; 75: 1018–24.
- Dieckmann K-P, Loy V. Persistent testicular intraepi-thelial neoplasia after chemotherapy. Eur Urol 1991; 20: 258–60.
- von der Maase H, Meinicke B, Skakkebaek NE. Residual carcinoma in situ of contralateral testis after chemother-apy. Lancet 1988; i: 477–8.
- Setchell BP. The functional significance of the blood-testis-barrier. J Androl 1980; 1: 3–11.
- Souchon R, Krege S. Schmoll H-J für die German Testicular Cancer Study Group. Interdisziplindrer Kon-sensus zur Diagnostik und Therapie von Hodentumoren. Strahlenther Onkol 2000; 176: 388–405.
- Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998; 9: 657–60.